Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Opdivo” drug pipelines has been added to ResearchAndMarkets.com’s offering. Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human…
OSAKA, Japan & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ai?src=hash" target="_blank"gt;#ailt;/agt;–Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and…
After Bristol-Myers Squibb (Bristol) said on Friday that it won’t ask FDA for faster approval of Opdivo/Yervoy combination for lung cancer, it agreed today with Ono Pharmaceutical to settle all patent-infringement charges related to Merck’s PD-1 antibody Keytruda.